Testing may include SAM, SAH, methionine, homocysteine, whole-blood histamine, copper, zinc, ceruloplasmin, urinary pyrroles, organic acids, lactate, pyruvate, glutathione-related markers, 8-OHdG and lipid peroxides when clinically appropriate
The FDA decision is anticipated in October 2025
vit D: vitamin D Note: This table has been modified from NCCN and ESMO guidelines Incidence and clinical outcome Elevations in pancreatic enzyme levels, even grade III toxicity are seen in 10-15% of the cases treated by ICIs, and this situation is frequent in clinical practice
Similar observations were noted in later human studies [56, 57], with the peak serum TMAO observed within hours following oral administration of the tracer [56]